Saturday 17 October 2026
Export ORIC’s income statement to Excel — free account
Oric Pharmaceuticals, Inc.
ORIC Healthcare Biotechnology
In the quarter to June 2026, EPS grew 19.2% and free cash flow fell 3.42%, each against the same quarter a year earlier.
12.35
0.42
−3.29%
Follow ORIC
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Current Ratio |
13.19 | 16.33 | 14.13 | 14.65 |
+8 more quarters Free account |
Net Debt/EBITDA |
5.92 | 7.19 | 8.17 | 7.77 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.76 | 0.91 | 0.74 | 0.77 | |
Capex/Depreciation |
(0.64) | 0.00 | (2.84) | 0.12 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow per Share |
(0.30) | (0.31) | (0.26) | (0.25) | |
Cash per Share |
2.45 | 2.67 | 3.21 | 2.90 | |
Shareholders Equity per Share |
3.53 | 3.94 | 4.38 | 4.11 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
3.53 | 3.94 | 4.38 | 4.11 | |
Free Cash Flow |
(31.96) | (32.44) | (22.71) | (25.15) | |
Working Capital |
252.94 | 272.46 | 268.05 | 275.42 | |
Capital Expenditures |
(0.36) | 0.00 | (0.23) | (0.03) | |
Net Current Asset Value |
250.27 | 269.03 | 263.94 | 271.32 | |
| Other line items | |||||
Quick Ratio |
12.76 | 15.86 | 13.79 | 14.23 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.29) | (0.31) | (0.26) | (0.25) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Payables |
3.50 | 4.03 | 2.69 | 3.57 | |
Average Assets |
375.77 | 339.81 | 341.52 | 366.63 | |
Average Common Equity |
352.63 | 317.65 | 313.74 | 340.46 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates